Sponsor Pipeline

Ray Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07439887 Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal… Stargardt Disease Recruiting
Phase 1
NCT06460844 Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia… Retinitis Pigmentosa Active, Not Recruiting
Not specified
NCT06375239 Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties… Retinitis Pigmentosa Recruiting
NCT07502664 Development and Evaluation of Functional Visual Field and Navigation Endpoints in… Retinitis Pigmentosa Recruiting
Get alerts when Ray Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free